A detailed history of Girard Partners Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Girard Partners Ltd. holds 21,976 shares of JNJ stock, worth $3.53 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
21,976
Previous 22,967 4.31%
Holding current value
$3.53 Million
Previous $3.63 Million 11.59%
% of portfolio
0.3%
Previous 0.34%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $143,080 - $156,359
-991 Reduced 4.31%
21,976 $3.21 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $532,715 - $558,523
3,432 Added 17.57%
22,967 $3.63 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $303,576 - $331,264
-2,085 Reduced 9.64%
19,535 $3.06 Million
Q3 2023

Nov 02, 2023

SELL
$155.75 - $174.48 $271,628 - $304,293
-1,744 Reduced 7.46%
21,620 $3.37 Million
Q2 2023

Aug 15, 2023

BUY
$154.35 - $166.11 $20,837 - $22,424
135 Added 0.58%
23,364 $3.87 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $971,251 - $1.16 Million
-6,430 Reduced 21.68%
23,229 $3.6 Million
Q4 2022

Jan 26, 2023

SELL
$160.2 - $179.79 $89,712 - $100,682
-560 Reduced 1.85%
29,659 $0
Q3 2022

Oct 20, 2022

SELL
$161.33 - $179.52 $561,589 - $624,909
-3,481 Reduced 10.33%
30,219 $4.94 Million
Q2 2022

Jul 26, 2022

SELL
$168.19 - $186.01 $341,089 - $377,228
-2,028 Reduced 5.68%
33,700 $5.98 Million
Q1 2022

Apr 27, 2022

SELL
$158.14 - $179.59 $2.84 Million - $3.22 Million
-17,951 Reduced 33.44%
35,728 $6.33 Million
Q4 2021

Feb 02, 2022

BUY
$155.93 - $173.01 $4,989 - $5,536
32 Added 0.06%
53,679 $9.18 Million
Q3 2021

Nov 01, 2021

BUY
$161.5 - $179.47 $7.26 Million - $8.07 Million
44,983 Added 519.19%
53,647 $8.66 Million
Q3 2021

Nov 01, 2021

SELL
$161.5 - $179.47 $6.92 Million - $7.69 Million
-42,851 Reduced 83.18%
8,664 $8.66 Million
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $8,771 - $9,408
-55 Reduced 0.11%
51,515 $8.49 Million
Q1 2021

May 06, 2021

SELL
$153.07 - $170.48 $10,867 - $12,104
-71 Reduced 0.14%
51,570 $8.48 Million
Q4 2020

Feb 02, 2021

SELL
$137.11 - $157.38 $219,787 - $252,280
-1,603 Reduced 3.01%
51,641 $8.13 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $591,140 - $647,778
-4,211 Reduced 7.33%
53,244 $7.93 Million
Q2 2020

Aug 10, 2020

SELL
$128.81 - $155.51 $603,346 - $728,408
-4,684 Reduced 7.54%
57,455 $8.08 Million
Q1 2020

May 01, 2020

BUY
$111.14 - $153.99 $75,686 - $104,867
681 Added 1.11%
62,139 $8.15 Million
Q4 2019

Feb 03, 2020

SELL
$127.5 - $146.44 $6,247 - $7,175
-49 Reduced 0.08%
61,458 $9.07 Million
Q3 2019

Nov 01, 2019

SELL
$126.95 - $142.14 $687,815 - $770,114
-5,418 Reduced 8.1%
61,507 $7.96 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $10,229 - $11,250
78 Added 0.12%
66,925 $9.32 Million
Q1 2019

May 08, 2019

BUY
$125.72 - $139.79 $20,869 - $23,205
166 Added 0.25%
66,847 $9.34 Million
Q4 2018

Feb 11, 2019

SELL
$122.84 - $147.84 $207,845 - $250,145
-1,692 Reduced 2.47%
66,681 $8.61 Million
Q3 2018

Nov 09, 2018

SELL
$121.58 - $142.88 $2.03 Million - $2.38 Million
-16,656 Reduced 19.59%
68,373 $9.45 Million
Q2 2018

Aug 07, 2018

BUY
$119.4 - $131.76 $61,132 - $67,461
512 Added 0.61%
85,029 $10.3 Million
Q1 2018

Apr 18, 2018

BUY
$125.1 - $148.14 $275,595 - $326,352
2,203 Added 2.68%
84,517 $10.8 Million
Q4 2017

Feb 07, 2018

BUY
$131.22 - $143.62 $31,099 - $34,037
237 Added 0.29%
82,314 $11.5 Million
Q3 2017

Nov 08, 2017

SELL
$129.47 - $135.38 $19,032 - $19,900
-147 Reduced 0.18%
82,077 $10.7 Million
Q2 2017

Aug 08, 2017

BUY
N/A
82,224
82,224 $10.9 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $420B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.